News

Curaleaf Partners with The Baldwin Fund for Breast Cancer Research

Curaleaf Partners with The Baldwin Fund for Breast Cancer Research

Curaleaf and The Baldwin Fund Unite for Breast Cancer Research

Curaleaf is celebrating a significant milestone this October as it continues its national at-register donation initiative during Breast Cancer Action Month. This initiative brings together communities and individuals to contribute towards essential breast cancer research. The funds raised will directly support The Carol M. Baldwin Breast Cancer Research Fund, widely known as The Baldwin Fund.

Continuing a Meaningful Legacy

Throughout October, customers visiting Curaleaf locations are encouraged to 'Round Up for Research' at checkout, enabling a seamless contribution to breast cancer research aimed at finding breakthroughs. This year, Curaleaf is thrilled to expand its impact across the nation through this special campaign, uniting customers around a shared goal of supporting vital research and honoring those affected by breast cancer.

The Baldwin Fund's Impact

The Baldwin Fund has an impressive history, having raised over $13 million in its fight against breast cancer for more than two decades. The organization is now embarking on a bold $50 million campaign designed to assist the Upstate Cancer Center in achieving National Cancer Institute (NCI) designation. This designation represents a high standard for innovative cancer programs and research.

The Message of Unity

Stephen Baldwin, representing The Baldwin Fund, highlights his mother's impactful mantra: "Together We Will Find a Cure." He emphasizes that this partnership provides an opportunity for individuals nationwide to contribute to cancer research. His belief in Curaleaf as a trusted and quality brand enhances the initiative's credibility and inspires customers to participate by simply rounding up their bills at the register.

Understanding the Importance of Breast Cancer Action Month

Every October, Curaleaf recognizes Breast Cancer Action Month as a vital occasion to stand united with its communities, customers, and patients. The company's chairman and CEO, Boris Jordan, asserts the importance of acknowledging individuals impacted by breast cancer. Through this partnership with The Baldwin Fund, Curaleaf invites customers to honor survivors and support their families while contributing to the research efforts aimed at eradicating this disease.

Cannabis and Cancer Care

While cannabis does not serve as a cancer treatment, many individuals living with breast cancer have reported that it assists in managing pain, anxiety, and other treatment-related side effects. Curaleaf is dedicated to offering high-quality cannabis options to patients and consumers. The company remains committed to advocating for more rigorous research on the role of cannabis in cancer care.

Participation Across Retail Locations

The at-register donation program will be available at most Curaleaf dispensaries nationwide, in accordance with state regulations. Participating states include Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, and Utah. This expansive reach allows for extensive community involvement in the critical mission of breast cancer research.

About Curaleaf Holdings

Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, focused on enhancing lives through the power of the plant. Renowned for its high-growth initiatives and quality assurance, Curaleaf offers a wide array of brands catering to both medical and adult use markets. The company strives to provide exceptional service, diverse product selections, and accessibility within the cannabis space.

About The Baldwin Fund

Founded by Carol M. Baldwin in 2001, The Baldwin Fund has raised significant funds to support groundbreaking cancer research and provide hope to those affected. Guided by the belief that collaboration leads to progress, the Baldwin Fund remains committed to expanding research efforts and support for all forms of cancer.

Frequently Asked Questions

What is the goal of Curaleaf's partnership with The Baldwin Fund?

The partnership aims to support breast cancer research through at-register donations, enhancing community engagement and funding critical research initiatives.

How can customers participate in the donation initiative?

Customers can participate by rounding up their purchases at checkout during the month of October at participating Curaleaf locations.

What has been the impact of The Baldwin Fund so far?

The Baldwin Fund has raised over $13 million in its 20 years of operation, contributing significantly to breast cancer research and patient care.

Why is Breast Cancer Action Month important?

Breast Cancer Action Month serves as an opportunity to raise awareness, honor survivors, and promote funding for research dedicated to ending breast cancer.

What role does cannabis play in cancer care according to Curaleaf?

Cannabis products may help manage symptoms such as pain and anxiety in patients undergoing cancer treatment, although cannabis is not a cure for cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 5

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 2

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 2

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
Hilarity and Hassles in NYC Co-op Life Exposed in New Book

Updated Category News Views 5

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 1

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware

Updated Category News Views 5

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 5

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 4

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading
Indiana American Water's PFAS Credits Total $25.5M

Updated Category News Views 2

Indiana American Water Dishes Out Big Buck Refunds Swing by Indiana American Water's latest move, and what do you see? A whopping $25.5 million in PFAS settlement credits being doled out to customers. That's right, this ain't your everyday water utility story—there's real money on the line here. Over four rounds of bill credits since November 2025, customers have seen...

Continue Reading
Aging at Home: The Real Costs and Obstacles Ahead

Updated Category News Views 2

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Continue Reading

Top 5 Most Recently Viewed Articles

DT Midstream Launches $300 Million Common Stock Offering

Updated Category News Views 135

DT Midstream Engages in Significant Public Stock Offering DT Midstream, Inc. (NYSE: DTM), based in Detroit, has announced an exciting development in its financial strategy with a public offering aimed at raising $300 million through the sale of common stock. As part of this offering, the company is poised to provide underwriters with a 30-day option to acquire up to an...

Continue Reading
Engaging Moments Ahead: Gyre Therapeutics at Major Conference

Updated Category News Views 147

Gyre Therapeutics' Upcoming Presentation at Major Conference Gyre Therapeutics, known for its innovative contribution to the field of biopharmaceuticals, is making waves in the industry. Based in San Diego, this company is dedicated to creating therapies that focus on fibrosis—a condition that can severely impact organ systems due to chronic diseases. Highlighting...

Continue Reading
Chemomab Presents Promising Nebokitug Data at BSG Live’25

Updated Category News Views 108

Chemomab Showcases Promising Results for Nebokitug at BSG Live’25 At the recent BSG Live’25 conference, Chemomab Therapeutics, Ltd. (NASDAQ: CMMB) unveiled exciting data from its Phase 2 SPRING trial concerning nebokitug, a novel treatment targeting primary sclerosing cholangitis (PSC). This oral presentation highlighted the robust clinical potential of nebokitug,...

Continue Reading
Integrated Power Services Prepares for PowerTest25 Success

Updated Category News Views 147

Integrated Power Services Set to Shine at PowerTest25 Integrated Power Services (IPS) is excited to announce its participation in PowerTest25, where it will highlight a comprehensive range of power management solutions. The event will take place in Orlando, and IPS is looking forward to connecting with attendees and showcasing its cutting-edge products and expertise....

Continue Reading
Exor N.V. Updates on Recent Share Buyback Activities

Updated Category News Views 134

Periodic Update on Exor N.V.'s Share Buyback Program Exor N.V. (AMS: EXO) has made significant strides in its ongoing share buyback initiative, demonstrating its commitment to enhancing shareholder value. Recently, the company announced substantial transactions under its second tranche of the buyback program, allocating up to €125 million to repurchase shares. These...

Continue Reading